Compounds > opc 12759
Page last updated: 2024-11-03

opc 12759 and Allergic Conjunctivitis

opc 12759 has been researched along with Allergic Conjunctivitis in 3 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Malhotra, C1
Singh, H1
Jain, AK1
Gupta, A1
Ram, J1
Ueta, M2
Sotozono, C2
Yokoi, N2
Kinoshita, S2
Koga, A1

Other Studies

3 other studies available for opc 12759 and Allergic Conjunctivitis

ArticleYear
Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.
    Ocular immunology and inflammation, 2022, Volume: 30, Issue:5

    Topics: Administration, Topical; Alanine; Conjunctivitis, Allergic; Cyclosporine; Humans; Immunologic Factor

2022
Rebamipide suppresses PolyI:C-stimulated cytokine production in human conjunctival epithelial cells.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:7

    Topics: Alanine; Animals; Antioxidants; Conjunctiva; Conjunctivitis, Allergic; Cytokines; Disease Models, An

2013
Usefulness of a new therapy using rebamipide eyedrops in patients with VKC/AKC refractory to conventional anti-allergic treatments.
    Allergology international : official journal of the Japanese Society of Allergology, 2014, Volume: 63, Issue:1

    Topics: Adolescent; Adult; Alanine; Anti-Allergic Agents; Child; Conjunctivitis, Allergic; Female; Humans; M

2014